Richard A. Colvin's most recent trade in Bluebird bio Inc was a trade of 584 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.92 per share. | 03 Mar 2025 | 584 | 7,610 (0%) | 0% | 3.9 | 2,289 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 03 Feb 2025 | 64 | 8,194 (0%) | 0% | 7.4 | 473 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 06 Jan 2025 | 19 | 8,257 (0%) | 0% | 9.3 | 176 | Common Stock |
| Bluebird bio Inc | Colvin Richard A. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.42 per share. | 10 Dec 2024 | 2,824 | 165,544 (0%) | 0% | 0.4 | 1,178 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 50,000 | 168,368 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 199,000 | 199,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.53 per share. | 01 Mar 2024 | 6,770 | 118,368 (0%) | 0% | 1.5 | 10,342 | Common Stock |
| Bluebird bio Inc | Richard Colvin A. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.42 per share. | 05 Jan 2024 | 597 | 125,138 (0%) | 0% | 1.4 | 845 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 55,000 | 128,078 (0%) | 0% | 0 | Common Stock | |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 01 Feb 2023 | 1,153 | 73,078 (0%) | 0% | 6.4 | 7,356 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.80 per share. | 11 Jan 2023 | 557 | 74,231 (0%) | 0% | 7.8 | 4,347 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.41 per share. | 04 Nov 2022 | 218 | 74,788 (0%) | 0% | 6.4 | 1,398 | Common Stock |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 60,000 | 60,000 | - | - | Stock Options (Right to buy) | |
| Bluebird bio Inc | Richard A. Colvin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 30,000 | 75,006 (0%) | 0% | 0 | Common Stock |